Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01NQM
|
||||
Former ID |
DIB009126
|
||||
Drug Name |
Lasmiditan
|
||||
Synonyms |
COL-144; LY-573144; Migraine therapy, CoLucid
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Colucid pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H18F3N3O2
|
||||
InChI |
InChI=1S/C19H18F3N3O2/c1-25-7-5-11(6-8-25)18(26)15-3-2-4-16(23-15)24-19(27)17-13(21)9-12(20)10-14(17)22/h2-4,9-11H,5-8H2,1H3,(H,23,24,27)
|
||||
InChIKey |
XEDHVZKDSYZQBF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1F receptor | Target Info | Agonist | [532737] | |
References | |||||
Ref 532737 | Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan. Neuropsychiatr Dis Treat. 2014 Mar 31;10:547-52. | ||||
Ref 540550 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3928). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.